ReP USP - Resultado da busca

Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Fonte: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Assuntos: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 31 out. 2024.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Artigo de periodico
Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community (2024)
Faustino, Vinicius Lima ; Visacri, Marilia Berlofa ; Aguiar, Patrícia Melo
Fonte: Journal of the American Pharmacists Association. Unidades: FCF, ICB
Assuntos: ASSISTÊNCIA À SAÚDE, DIVERSIDADE SEXUAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAUSTINO, Vinicius Lima e VISACRI, Marilia Berlofa e AGUIAR, Patrícia Melo. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community. Journal of the American Pharmacists Association, v. 64, n. 3, p. 1-3 art. 102066, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.japh.2024.102066. Acesso em: 31 out. 2024.
APA
Faustino, V. L., Visacri, M. B., & Aguiar, P. M. (2024). Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community. Journal of the American Pharmacists Association, 64( 3), 1-3 art. 102066. doi:10.1016/j.japh.2024.102066
NLM
Faustino VL, Visacri MB, Aguiar PM. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community [Internet]. Journal of the American Pharmacists Association. 2024 ; 64( 3): 1-3 art. 102066.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1016/j.japh.2024.102066
Vancouver
Faustino VL, Visacri MB, Aguiar PM. Toward inclusive health care: pharmacists’ perceptions on academic preparedness and health care provision for the LGBTQIA+ community [Internet]. Journal of the American Pharmacists Association. 2024 ; 64( 3): 1-3 art. 102066.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1016/j.japh.2024.102066
Trabalho de evento-resumo
Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models (2023)
Carlos, Jorge Antonio Elias Godoy ; Almeida, Larissa Costa de ; Lima, Keli; Tavares, Maurício Temotheo ; Waitman, Karoline de Barros ; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: ICB, FCF
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 31 out. 2024.
APA
Carlos, J. A. E. G., Almeida, L. C. de, Lima, K., Tavares, M. T., Waitman, K. de B., Costa-Lotufo, L. V., et al. (2023). Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Carlos JAEG, Almeida LC de, Lima K, Tavares MT, Waitman K de B, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models [Internet]. Anais. 2023 ;[citado 2024 out. 31 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Carlos JAEG, Almeida LC de, Lima K, Tavares MT, Waitman K de B, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models [Internet]. Anais. 2023 ;[citado 2024 out. 31 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Trabalho de evento-resumo
Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2023)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Carlos, Jorge Antonio Elias Godoy ; Kronenberger, Thales ; Toledo, Mônica Franco Zannini Junqueira ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho ; Parise Filho, Roberto
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: FCF, ICB
Assuntos: NEOPLASIAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 31 out. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Carlos, J. A. E. G., Kronenberger, T., Toledo, M. F. Z. J., et al. (2023). Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Costa-Lotufo LV, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 out. 31 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Costa-Lotufo LV, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 out. 31 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Artigo de periodico
Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)
Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Fonte: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF
Assuntos: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 31 out. 2024.
APA
Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079
NLM
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 out. 31 ] Available from: https://doi.org/10.33263/BRIAC131.079
Vancouver
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 out. 31 ] Available from: https://doi.org/10.33263/BRIAC131.079
Trabalho de evento-resumo
Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2022)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Toledo, Mônica Franco Zannini Junqueira ; Machado Neto, João Agostinho ; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química. Unidades: FCF, ICB
Assuntos: NEOPLASIAS, PURINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2022, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2022. Disponível em: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf. Acesso em: 31 out. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Toledo, M. F. Z. J., Machado Neto, J. A., Costa-Lotufo, L. V., & Parise Filho, R. (2022). Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Toledo MFZJ, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2022 ;[citado 2024 out. 31 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Toledo MFZJ, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2022 ;[citado 2024 out. 31 ] Available from: http://www.sbq.org.br/45ra/anexos/45RASBQ_resumos.pdf
Artigo de periodico
Besifloxacin nanocrystal: towards an innovative ophthalmic preparation (2022)
Jesus, José Izo Santana da Silva de ; Lourenço, Felipe Rebello ; Ishida, Kelly ; Barreto, Thayná Lopes ; Avino, Valdir Carlos ; Santos Neto, Edson dos; Bou-Chacra, Nadia Araci
Fonte: Pharmaceutics. Unidades: FCF, ICB
Assuntos: INFECÇÕES OCULARES, ANTIBIÓTICOS, CONJUNTIVITE VIRAL, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, José Izo Santana da Silva de et al. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, v. 14, p. 1-21 art. 2221, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102221. Acesso em: 31 out. 2024.
APA
Jesus, J. I. S. da S. de, Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Santos Neto, E. dos, & Bou-Chacra, N. A. (2022). Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, 14, 1-21 art. 2221. doi:10.3390/pharmaceutics14102221
NLM
Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
Vancouver
Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
Trabalho de evento-resumo periodico
Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models (2022)
Carlos, Jorge Antonio Elias Godoy ; Almeida, L C; Lima, K; Tavares, M T; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Fonte: Hematology, Transfusion and Cell Therapy. Nome do evento: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Assunto: ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.265. Acesso em: 31 out. 2024. , 2022
APA
Carlos, J. A. E. G., Almeida, L. C., Lima, K., Tavares, M. T., Costa-Lotufo, L. V., Parise Filho, R., & Machado Neto, J. A. (2022). Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.265
NLM
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265
Vancouver
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265
Trabalho de evento-resumo periodico
A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells (2022)
Jaeg, Carlos; Almeida, LC; Lima, K; Tavares, M. T; Waitman, K. B; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Fonte: Hematology, Transfusion and Cell Therapy. Nome do evento: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Assuntos: INIBIDORES DE ENZIMAS, APOPTOSE, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAEG, Carlos et al. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.267. Acesso em: 31 out. 2024. , 2022
APA
Jaeg, C., Almeida, L. C., Lima, K., Tavares, M. T., Waitman, K. B., Costa-Lotufo, L. V., et al. (2022). A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.267
NLM
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Vancouver
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Artigo de periodico
Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention (2021)
Apolinário, Alexsandra Conceição ; Hauschke, Leon; Nunes, Jessica Ribeiro ; Lourenço, Felipe Rebello ; Lopes, Luciana Biagini
Fonte: Colloids and Surfaces A. Unidades: FCF, ICB
Assuntos: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, QUIMIOTERÁPICOS, SOLUBILIDADE, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, v. 623, n. 20, p. 1-14 art. 126745, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.126745. Acesso em: 31 out. 2024.
APA
Apolinário, A. C., Hauschke, L., Nunes, J. R., Lourenço, F. R., & Lopes, L. B. (2021). Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, 623( 20), 1-14 art. 126745. doi:10.1016/j.colsurfa.2021.126745
NLM
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Vancouver
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Artigo de periodico
Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis (2021)
Yukuyama, Megumi Nishitani ; Ishida, Kelly ; Araujo, Gabriel Lima Barros de ; Spadari, Cristina de Castro ; Souza, Aline de ; Löbenberg, Raimar ; Henostroza, Mirla Anali Bazan; Folchini, Beatriz Rabelo; Peroni, Camilla Midori; Peters, Maria Christina Camasmie ; Oliveira, Isabela Fernandes de; Miyagi, Mariana Yasue Saito ; Bou-Chacra, Nadia Araci
Fonte: Colloids and Surfaces A. Unidades: ICB, FCF
Assuntos: MENINGITE, ANTIFÚNGICOS, PLANEJAMENTO DE FÁRMACOS, CRIPTOCOCOSE, EMULSÕES (FORMAS FARMACÊUTICAS), CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKUYAMA, Megumi Nishitani et al. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, v. 630, p. 1-10 art. 127631, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.127631. Acesso em: 31 out. 2024.
APA
Yukuyama, M. N., Ishida, K., Araujo, G. L. B. de, Spadari, C. de C., Souza, A. de, Löbenberg, R., et al. (2021). Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis. Colloids and Surfaces A, 630, 1-10 art. 127631. doi:10.1016/j.colsurfa.2021.127631
NLM
Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
Vancouver
Yukuyama MN, Ishida K, Araujo GLB de, Spadari C de C, Souza A de, Löbenberg R, Henostroza MAB, Folchini BR, Peroni CM, Peters MCC, Oliveira IF de, Miyagi MYS, Bou-Chacra NA. Rational design of oral flubendazole-loaded nanoemulsion for brain delivery in Cryptococcosis [Internet]. Colloids and Surfaces A. 2021 ; 630 1-10 art. 127631.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.127631
Artigo de periodico
Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing (2021)
Fernandez, Sandra Costa; Mattos, Jenyffer K. R; Scheunemann, Gaby Soares ; Salata, Giovanna Cassone ; Chorilli, Marlus ; Watanabe, Ii-sei ; Araujo, Gabriel Lima Barros de ; Santos, Marinilce Fagundes dos ; Ishida, Kelly ; Lopes, Luciana Biagini
Fonte: International Journal of Biological Macromolecules. Unidades: ICB, FCF
Assuntos: ANTIOXIDANTES, LIPÍDEOS, ANATOMIA, BIOLOGIA CELULAR, MICROBIOLOGIA, QUITOSANA, CICATRIZAÇÃO, FERIMENTOS E LESÕES, MATERIAIS NANOESTRUTURADOS, ÓLEOS VEGETAIS, PLANTAS OLEAGINOSAS, FIBROBLASTOS, FOLHAS (PLANTAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDEZ, Sandra Costa et al. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing. International Journal of Biological Macromolecules, v. 183, p. 668-680, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2021.04.168. Acesso em: 31 out. 2024.
APA
Fernandez, S. C., Mattos, J. K. R., Scheunemann, G. S., Salata, G. C., Chorilli, M., Watanabe, I. -sei, et al. (2021). Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing. International Journal of Biological Macromolecules, 183, 668-680. doi:10.1016/j.ijbiomac.2021.04.168
NLM
Fernandez SC, Mattos JKR, Scheunemann GS, Salata GC, Chorilli M, Watanabe I-sei, Araujo GLB de, Santos MF dos, Ishida K, Lopes LB. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing [Internet]. International Journal of Biological Macromolecules. 2021 ; 183 668-680.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ijbiomac.2021.04.168
Vancouver
Fernandez SC, Mattos JKR, Scheunemann GS, Salata GC, Chorilli M, Watanabe I-sei, Araujo GLB de, Santos MF dos, Ishida K, Lopes LB. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing [Internet]. International Journal of Biological Macromolecules. 2021 ; 183 668-680.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ijbiomac.2021.04.168
Artigo de periodico
Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole (2020)
Passos, Julia Sapienza ; Martino, Luiza Capello de; Dartora, Vanessa Franco Carvalho; Araujo, Gabriel Lima Barros de ; Ishida, Kelly ; Lopes, Luciana Biagini
Fonte: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB
Assuntos: MICROBIOLOGIA, FARMACOLOGIA, NANOPARTÍCULAS, ANTIFÚNGICOS, PELE, ESPOROTRICOSE, DERMATOPATIAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, v. 149, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105296. Acesso em: 31 out. 2024.
APA
Passos, J. S., Martino, L. C. de, Dartora, V. F. C., Araujo, G. L. B. de, Ishida, K., & Lopes, L. B. (2020). Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, 149, 11 . doi:10.1016/j.ejps.2020.105296
NLM
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Vancouver
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Artigo de periodico
Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis (2020)
Ribeiro, João A.; Hammer, Alexander ; Zuniga, Gerardo A. Libreros ; Pacheco, Sair Maximo Chavez ; Tyrakis, Petros ; Oliveira, Gabriel S. de; Kirkman, Timothy ; Bakali, Jamal El ; Rocco, Silvana A. ; Sforça, Mauricio L. ; Parise Filho, Roberto ; Coyne, Anthony G. ; Blundell, Tom L. ; Abell, Chris ; Dias, Marcio Vinicius Bertacine
Fonte: ACS Infectious Diseases. Unidades: FCF, ICB
Assuntos: MYCOBACTERIUM TUBERCULOSIS, ÁCIDO FÓLICO, MICROBIOLOGIA, INIBIDORES DE ENZIMAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, João A. et al. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis. ACS Infectious Diseases, v. 6, p. 2192−2201 : + Supplementary materials ( S1-S16), 2020Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.0c00263. Acesso em: 31 out. 2024.
APA
Ribeiro, J. A., Hammer, A., Zuniga, G. A. L., Pacheco, S. M. C., Tyrakis, P., Oliveira, G. S. de, et al. (2020). Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis. ACS Infectious Diseases, 6, 2192−2201 : + Supplementary materials ( S1-S16). doi:10.1021/acsinfecdis.0c00263
NLM
Ribeiro JA, Hammer A, Zuniga GAL, Pacheco SMC, Tyrakis P, Oliveira GS de, Kirkman T, Bakali JE, Rocco SA, Sforça ML, Parise Filho R, Coyne AG, Blundell TL, Abell C, Dias MVB. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis [Internet]. ACS Infectious Diseases. 2020 ; 6 2192−2201 : + Supplementary materials ( S1-S16).[citado 2024 out. 31 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00263
Vancouver
Ribeiro JA, Hammer A, Zuniga GAL, Pacheco SMC, Tyrakis P, Oliveira GS de, Kirkman T, Bakali JE, Rocco SA, Sforça ML, Parise Filho R, Coyne AG, Blundell TL, Abell C, Dias MVB. Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis [Internet]. ACS Infectious Diseases. 2020 ; 6 2192−2201 : + Supplementary materials ( S1-S16).[citado 2024 out. 31 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00263
Artigo de periodico
Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors (2020)
Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Souza, Alfredo Danilo Ferreira de ; Santos, Soraya da Silva; Poso, Antti ; Ribeiro, João Augusto; Tavares, Maurício Temotheo ; Pavan, Fernando Rogério ; Trossini, Gustavo Henrique Goulart ; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Fonte: Bioorganic & Medicinal Chemistry. Unidades: FCF, ICB
Assuntos: MICROBIOLOGIA, METABÓLITOS, ÁCIDOS CARBOXÍLICOS, DNA, TUBERCULOSE, CINÉTICA QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, v. 28, n. 15, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115600. Acesso em: 31 out. 2024.
APA
Kronenberger, T., Ferreira, G. M., Souza, A. D. F. de, Santos, S. da S., Poso, A., Ribeiro, J. A., et al. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, 28( 15), 10 . doi:10.1016/j.bmc.2020.115600
NLM
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Vancouver
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Artigo de periodico
Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum (2019)
Vasconcelos, Stanley Nunes Siqueira ; Meissner, Kamila Anna ; Ferraz, Witor R.; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten ; Stefani, Hélio Alexandre
Fonte: Future Medicinal Chemistry. Unidades: FCF, ICB
Assuntos: MALÁRIA, PLASMODIUM FALCIPARUM, PROTOZOA, ANTIMALÁRICOS, ANIMAIS PARASITOS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASCONCELOS, Stanley Nunes Siqueira et al. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum. Future Medicinal Chemistry, v. 11, n. 6, p. 525-538, 2019Tradução . . Disponível em: https://doi.org/10.4155/fmc-2018-0246. Acesso em: 31 out. 2024.
APA
Vasconcelos, S. N. S., Meissner, K. A., Ferraz, W. R., Trossini, G. H. G., Wrenger, C., & Stefani, H. A. (2019). Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum. Future Medicinal Chemistry, 11( 6), 525-538. doi:10.4155/fmc-2018-0246
NLM
Vasconcelos SNS, Meissner KA, Ferraz WR, Trossini GHG, Wrenger C, Stefani HA. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum [Internet]. Future Medicinal Chemistry. 2019 ; 11( 6): 525-538.[citado 2024 out. 31 ] Available from: https://doi.org/10.4155/fmc-2018-0246
Vancouver
Vasconcelos SNS, Meissner KA, Ferraz WR, Trossini GHG, Wrenger C, Stefani HA. Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum [Internet]. Future Medicinal Chemistry. 2019 ; 11( 6): 525-538.[citado 2024 out. 31 ] Available from: https://doi.org/10.4155/fmc-2018-0246
Artigo de periodico
Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting (2019)
Dartora, Vanessa Franco Carvalho ; Salata, Giovanna Cassone ; Matos, Jenyffer Kelly Rocha de ; Fernandez, Sandra Costa; Chorilli, Marlus ; Steiner, Alexandre Alarcon ; Araujo, Gabriel Lima Barros de ; Silveira, Edilberto Rocha ; Costa-Lotufo, Letícia Veras ; Lopes, Luciana Biagini
Fonte: International Journal of Pharmaceutics. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, IMUNOLOGIA, NEOPLASIAS MAMÁRIAS, CITOTOXICIDADE IMUNOLÓGICA, QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARTORA, Vanessa Franco Carvalho et al. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, v. 567, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2019.118460. Acesso em: 31 out. 2024.
APA
Dartora, V. F. C., Salata, G. C., Matos, J. K. R. de, Fernandez, S. C., Chorilli, M., Steiner, A. A., et al. (2019). Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, 567, 13 . doi:10.1016/j.ijpharm.2019.118460
NLM
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460
Vancouver
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460
Trabalho de evento-resumo periodico
Development of lipid nanocarriers with antibacterial and antioxidant properties for application in wound healing (2018)
Costa-Fernandez, Sandra; Matos, Jenyffer Kelly Rocha de; Scheunemann, Gaby Soares; Ii-sei Watanabe; Araujo, Gabriel Lima Barros de ; Ishida, Kelly ; Lopes, Luciana Biagini
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidades: ICB, FCF
Assuntos: ANTIOXIDANTES, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-FERNANDEZ, Sandra et al. Development of lipid nanocarriers with antibacterial and antioxidant properties for application in wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 31 out. 2024. , 2018
APA
Costa-Fernandez, S., Matos, J. K. R. de, Scheunemann, G. S., Ii-sei Watanabe,, Araujo, G. L. B. de, Ishida, K., & Lopes, L. B. (2018). Development of lipid nanocarriers with antibacterial and antioxidant properties for application in wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Costa-Fernandez S, Matos JKR de, Scheunemann GS, Ii-sei Watanabe, Araujo GLB de, Ishida K, Lopes LB. Development of lipid nanocarriers with antibacterial and antioxidant properties for application in wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 62 res. 258.[citado 2024 out. 31 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Costa-Fernandez S, Matos JKR de, Scheunemann GS, Ii-sei Watanabe, Araujo GLB de, Ishida K, Lopes LB. Development of lipid nanocarriers with antibacterial and antioxidant properties for application in wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 62 res. 258.[citado 2024 out. 31 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Artigo de periodico
Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening (2018)
Meissner, Kamila Anna ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten
Fonte: Chemical Biology and Drug Design. Unidades: FCF, ICB
Assuntos: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 31 out. 2024.
APA
Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
NLM
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/cbdd.13416
Vancouver
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/cbdd.13416
Artigo de periodico
Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
Fernandes, Thais Batista; Azevedo, Ricardo Alexandre de; Yang, Rosania; Teixeira, Sarah Fernandes; Trossini, Gustavo Henrique Goulart ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber; Parise Filho, Roberto
Fonte: Letters in Drug Design and Discovery. Unidades: FCF, ICB
Assuntos: APOPTOSE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 31 out. 2024.
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 out. 31 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 out. 31 ] Available from: https://doi.org/10.2174/1570180815666180321161513

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos